Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Onvatilimab |
Trade Name | |
Synonyms | CI 8993|CI8993|CI-8993|JNJ 61610588|JNJ61610588|JNJ-61610588 |
Drug Descriptions |
Onvatilimab (CI-8993) is a monoclonal antibody that targets and binds to VSIR (VISTA; PD-1H) on immune cells leading to decreased VSIR-mediated signaling and potentially resulting in activation of anti-tumor immune response and inhibition of tumor cell growth (NCI Drug Dictionary). |
DrugClasses | VSIR Antibody 6 |
CAS Registry Number | NA |
NCIT ID | C177901 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Onvatilimab | Onvatilimab | 0 | 2 |